The clinical value of squamous cell carcinoma antigen in patients irradiated for locally advanced cancer of the head and neck

被引：0
|
作者：
Micke, O
Bruns, F
Schäfer, U
Horst, E
Büntzel, J
Willich, N
机构：
[1] Univ Klinikum Munster, Klin & Poliklin Strahlentherapie Radioonkol, D-48129 Munster, Germany
[2] Sudharz Krankenhaus Nordhausen GmbH, HNO Klin, D-99734 Nordhausen, Germany
来源：
ANTICANCER RESEARCH | 2003年 / 23卷 / 2A期
关键词：
SCC; squamous cell carcinoma antigen; head and neck cancer; radiochemotherapy; radiotherapy;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Purpose: This study examines the value of squamous cell cancer (SCC) antigen in patients irradiated for locally advanced cancer of the head and neck. Materials and Methods: In 20 patients (group A) treated with radiochemotherapy and in 20 patients (group B) receiving postoperative it-radiation serum SCC values were investigated. Results: The pretreatment SCC level was 1.6 ng/ml in group A and 1.3 ng/ml in group B. In group A 15 % had elevated serum SCC levels above the cut-off level. In group B there were 10 %. During follow-up (median 20 months),. 10 patients in group A and 8 in group B suffered from a recurrent or progressing disease. Of these 20 % in group A and 12.5 % in group B had elevated SCC levels. Conclusion: Our results suggest that, in the described patient groups, SCC is probably of low value for tumor diagnosis and follow-up.
引用
收藏
页码：907 / 911
页数：5
相关论文
共 50 条
  • [41] Squamous Cell Carcinoma Antigen in the Follow-up of Patients With Head and Neck Cancer
    Schepens, Emma J. A.
    Al-Mamgani, Abrahim
    Karssemakers, Luc H. E.
    van den Broek, Daan
    van den Brekel, Michiel. W. M.
    Lopez-Yurda, Marta
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2024, 170 (02) : 422 - 430
  • [42] Clinical Value of Endoscopic Esophageal Screening in Head and Neck Squamous Cell Carcinoma Patients
    Chen, Wei-Chih
    Wu, Ching-Nung
    Wang, Yu-Ming
    Chiu, Tai-Jan
    Wu, Shao-Chun
    Yang, Yao-Hsu
    Luo, Sheng-Dean
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2024, 170 (01) : 141 - 150
  • [43] Prognostic value of advanced lung cancer inflammation index in head and neck squamous cell carcinoma
    Bernhard J. Jank
    Lorenz Kadletz
    Julia Schnöll
    Edgar Selzer
    Christos Perisanidis
    Gregor Heiduschka
    European Archives of Oto-Rhino-Laryngology, 2019, 276 : 1487 - 1492
  • [44] Prognostic value of advanced lung cancer inflammation index in head and neck squamous cell carcinoma
    Jank, Bernhard J.
    Kadletz, Lorenz
    Schnoell, Julia
    Selzer, Edgar
    Perisanidis, Christos
    Heiduschka, Gregor
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2019, 276 (05) : 1487 - 1492
  • [45] THE VALUE OF SQUAMOUS-CELL CARCINOMA ANTIGEN IN PATIENTS WITH LOCALLY ADVANCED CERVICAL-CANCER UNDERGOING NEOADJUVANT CHEMOTHERAPY
    SCAMBIA, G
    PANICI, PB
    BAIOCCHI, G
    AMOROSO, M
    FOTI, E
    GREGGI, S
    MANCUSO, S
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1991, 164 (02) : 631 - 636
  • [46] The clinical value of serum squamous cell carcinoma 1 and 2 in head and neck squamous cell carcinoma
    Yasumatsu, Ryuji
    Nakano, Takafumi
    Hashimoto, Kazuki
    Kogo, Ryunosuke
    Wakasaki, Takahiro
    Nakagawa, Takashi
    AURIS NASUS LARYNX, 2019, 46 (01) : 135 - 140
  • [47] Diabetes management during chemoradiation in patients with locally advanced mucosal head and neck squamous cell carcinoma
    Mellor, Rhiannon
    Girgis, Christian
    Rodrigues, Anthony
    Chen, Charley
    Cuan, Sonia
    Gambhir, Parvind
    Perera, Lakmalie
    Veness, Michael
    Sundaresan, Purnima
    Gao, Bo
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 : 42 - 42
  • [48] Management of dermatitis in patients with locally advanced squamous cell carcinoma of the head and neck receiving cetuximab and radiotherapy
    Cabezon Gutierrez, Luis
    Khosravi-Shahi, Parham
    Escobar Alvarez, Yolanda
    ORAL ONCOLOGY, 2012, 48 (04) : 293 - 297
  • [49] Induction chemotherapy with the EXTREME regimen in frail patients with locally advanced head and neck squamous cell carcinoma
    Valérie Cochin
    Erwan de Mones
    Laurence Digue
    Muriel Garcia-Ramirez
    Charles Dupin
    Claire Majoufre
    Philipe Fernandez
    Amaury Daste
    Targeted Oncology, 2018, 13 : 247 - 252
  • [50] THE USE OF MUGARD(TM) AND CAPHOSOL(R) IN PATIENTS WITH LOCALLY ADVANCED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
    Pettit, L.
    Davis, G.
    Whitmarsh, S.
    Sanghera, P.
    Hartley, A.
    RADIOTHERAPY AND ONCOLOGY, 2011, 98 : S25 - S25
12345